Greg Raskin
About Greg Raskin
Greg Raskin is a lecturer in the Department of Economics at Yale University and serves as Senior Vice President of Technology Development at Memorial Sloan Kettering Cancer Center. He holds a BA in Molecular Biophysics and Biochemistry and an MD from Yale, and has held various leadership roles in healthcare and finance.
Work at Yale University
Greg Raskin has served as a Lecturer in the Department of Economics at Yale University since 2017. His role involves teaching and engaging with students in economic theories and applications. Raskin's academic background, including a BA in Molecular Biophysics and Biochemistry from Yale, supports his teaching in this prestigious institution located in the Greater New York City Area.
Education and Expertise
Greg Raskin completed his undergraduate studies at Yale University, earning a Bachelor of Arts in Molecular Biophysics and Biochemistry from 1990 to 1994. He furthered his education at Yale School of Medicine, where he obtained his Doctor of Medicine degree from 1994 to 1998. This combination of education in both economics and medicine provides Raskin with a unique perspective in his professional roles.
Professional Experience
Greg Raskin has held various significant positions throughout his career. He currently serves as Senior Vice President of Technology Development at Memorial Sloan Kettering Cancer Center, a role he has occupied since 2021. Prior to this, he was Vice President of Technology Development at the same institution from 2012 to 2021. Raskin also worked at Y-mAbs Therapeutics, Inc. as a Board Director from 2015 to 2020 and held the position of Engagement Manager at McKinsey & Co. from 1999 to 2002.
Previous Roles and Contributions
Before his current roles, Greg Raskin was Vice President of Early Stage Growth at AllianceBernstein LP from 2005 to 2012. He also gained clinical experience as a Resident Physician in the Department of Internal Medicine at NYU Langone Medical Center from 1998 to 1999. His diverse professional background spans economics, technology development, and healthcare, showcasing his multifaceted expertise.